Notice: This company has been marked as potentially delisted and may not be actively trading. Innovate Biopharmaceuticals (INNT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends INNT vs. SCPS, VAXX, CALA, ARDS, EVLO, AMPE, CMRA, EFTR, ONCSQ, and AEHAWShould you be buying Innovate Biopharmaceuticals stock or one of its competitors? The main competitors of Innovate Biopharmaceuticals include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Calithera Biosciences (CALA), Aridis Pharmaceuticals (ARDS), Evelo Biosciences (EVLO), Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), and Aesther Healthcare Acquisition (AEHAW). Innovate Biopharmaceuticals vs. Scopus BioPharma Vaxxinity Calithera Biosciences Aridis Pharmaceuticals Evelo Biosciences Ampio Pharmaceuticals Comera Life Sciences eFFECTOR Therapeutics OncoSec Medical Aesther Healthcare Acquisition Scopus BioPharma (NASDAQ:SCPS) and Innovate Biopharmaceuticals (NASDAQ:INNT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, community ranking, earnings, institutional ownership, media sentiment and dividends. Which has more risk and volatility, SCPS or INNT? Scopus BioPharma has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500. Comparatively, Innovate Biopharmaceuticals has a beta of -0.39, meaning that its share price is 139% less volatile than the S&P 500. Does the media prefer SCPS or INNT? In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Innovate Biopharmaceuticals'average media sentiment score. Company Overall Sentiment Scopus BioPharma Neutral Innovate Biopharmaceuticals Neutral Is SCPS or INNT more profitable? Company Net Margins Return on Equity Return on Assets Scopus BioPharmaN/A N/A N/A Innovate Biopharmaceuticals N/A N/A -234.42% Which has preferable earnings and valuation, SCPS or INNT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScopus BioPharmaN/AN/A-$11.61MN/AN/AInnovate BiopharmaceuticalsN/AN/A-$27.05MN/AN/A Do insiders & institutionals have more ownership in SCPS or INNT? 5.9% of Innovate Biopharmaceuticals shares are owned by institutional investors. 5.1% of Scopus BioPharma shares are owned by company insiders. Comparatively, 7.9% of Innovate Biopharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor SCPS or INNT? Innovate Biopharmaceuticals received 201 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 65.48% of users gave Innovate Biopharmaceuticals an outperform vote. CompanyUnderperformOutperformScopus BioPharmaOutperform Votes2100.00% Underperform VotesNo VotesInnovate BiopharmaceuticalsOutperform Votes20365.48% Underperform Votes10734.52% SummaryScopus BioPharma beats Innovate Biopharmaceuticals on 4 of the 7 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INNT vs. The Competition Export to ExcelMetricInnovate BiopharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$8,000.00$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E Ratio-1.7910.5990.0517.18Price / SalesN/A196.061,116.25117.05Price / CashN/A57.1643.1037.85Price / BookN/A5.094.784.78Net Income-$27.05M$151.83M$120.31M$225.60M Innovate Biopharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INNTInnovate BiopharmaceuticalsN/AN/AN/AN/A$8,000.00N/A-1.798SCPSScopus BioPharmaN/A$0.00flatN/A-99.3%$13,000.00N/A0.009Gap DownVAXXVaxxinityN/A$0.00+9,900.0%N/A-100.0%$13,000.00$70,000.000.0090CALACalithera BiosciencesN/A$0.00+2,300.0%N/A-99.7%$12,000.00$9.75M0.0060Analyst ForecastGap UpARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.9%$11,000.00$3.09M0.0030News CoverageEVLOEvelo BiosciencesN/A$0.00+66.7%N/A-99.1%$9,000.00N/A0.00120Gap UpAMPEAmpio PharmaceuticalsN/A$0.00-27.8%N/A-99.9%$3,000.00N/A0.0020Analyst ForecastGap DownCMRAComera Life SciencesN/AN/AN/AN/A$3,000.00$630,000.000.002Gap UpEFTReFFECTOR TherapeuticsN/A$0.00flat$24.00+11,999,900.0%-100.0%$1,000.00$3.55M0.0010ONCSQOncoSec MedicalN/A$0.00-99.8%N/AN/A$1,000.00N/A0.0040Gap DownAEHAWAesther Healthcare AcquisitionN/A$0.03-22.7%N/A+22.1%$0.00N/A0.002 Related Companies and Tools Related Companies SCPS Competitors VAXX Competitors CALA Competitors ARDS Competitors EVLO Competitors AMPE Competitors CMRA Competitors EFTR Competitors ONCSQ Competitors AEHAW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INNT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovate Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovate Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INNT Stock Alerts